Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.83 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.63 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.63 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.60 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.60 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | LCK | P06239 | 1/20 | 0.57 |
| ▸ | PPARD | Q03181 | 1/20 | 0.57 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.57 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL167273 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL10788879 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL1704587 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| Hexane SCHEMBL4788148 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL249553 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL2492860 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL17329112 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| Hexane SCHEMBL18237384 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL3003696 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL1645242 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240307295-A1 | METHODS FOR TREATING GOUT AND BONE DECALCIFICATION | DYVE BIOSCIENCES INC (US) | 2024-09-19 | — | — | US | claimed |
| US-11793830-B2 | Method of administration and treatment | DYVE BIOSCIENCES, INC. (US) | 2023-10-24 | — | — | US | claimed |
| US-11744853-B2 | Method of administration and treatment | DYVE BIOSCIENCES, INC. (US) | 2023-09-05 | — | — | US | claimed |
| WO-2023092145-A1 | METHODS FOR TREATING GOUT AND BONE DECALCIFICATION BY TRANSDERMALLY ADMINISTERING BUFFERING AGENTS | DYVE BIOSCIENCES, INC. (US) | 2023-05-25 | — | — | WO | claimed |
| US-11389472-B2 | Method of administration and treatment | DYVE BIOSCIENCES, INC. (US) | 2022-07-19 | — | — | US | claimed |
| US-11357792-B2 | Method of administration and treatment | Dyvve Biosciences, Inc. (US) | 2022-06-14 | — | — | US | claimed |
| US-20220062329-A1 | METHOD OF ADMINISTRATION AND TREATMENT | DYVE BIOSCIENCES, INC. | 2022-03-03 | — | — | US | claimed |
| US-20220047624-A1 | METHOD OF ADMINISTRATION AND TREATMENT | DYVE BIOSCIENCES, INC. | 2022-02-17 | — | — | US | claimed |
| US-20220040225-A1 | METHOD OF ADMINISTRATION AND TREATMENT | DYVE BIOSCIENCES, INC. | 2022-02-10 | — | — | US | claimed |
| US-20220023336-A1 | METHOD OF ADMINISTRATION AND TREATMENT | DYVE BIOSCIENCES, INC. | 2022-01-27 | — | — | US | claimed |
| CN-101296691-A | transdermal drug delivery dosage form | NUVO RES INC (CA) | 2008-10-29 | — | — | CN | claimed |
| EP-1909772-A1 | TRANSDERMAL DRUG DELIVERY FORMULATION | Nuvo Research Inc. (CA) | 2008-04-16 | — | — | EP | claimed |
| US-20070269379-A1 | Penetration Enhancer Combinations for Transdermal Delivery | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2007-11-22 | — | — | US | claimed |
| WO-2007098591-A2 | TOPICAL NAIL FORMULATION | NUVO RESEARCH INC. (CA) | 2007-09-07 | — | — | WO | claimed |
| US-20070122508-A1 | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | HELIXIR CO., LTD. (KR) | 2007-05-31 | — | — | US | claimed |
| WO-2007016766-A1 | TRANSDERMAL DRUG DELIVERY FORMULATION | NUVO RESEARCH INC. (CA) | 2007-02-15 | — | — | WO | claimed |
| WO-2005009510-A2 | PENETRATION ENHANCER COMBINATIONS FOR TRANSDERMAL DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-02-03 | — | — | WO | claimed |
| EP-0940138-A1 | LUBRICATION ASSISTANT AND PROCESS FOR THE PREPARATION OF ETHYL STEARATE USED THEREIN | Seiken Chemical Co., Ltd. (JP) | 1999-09-08 | — | — | EP | claimed |
| EP-0508153-A2 | Solid ink compositions for thermal ink-jet printing having improved printing characteristics | Hewlett-Packard Company (US) | 1992-10-14 | — | — | EP | claimed |
| US-5065167-A | Vaporizable solid ink composition for thermal ink-jet printing | HEWLETT-PACKARD COMPANY (US) | 1991-11-12 | — | — | US | claimed |